Bridgewater, NJ, United States of America

Charles Minnan Cheng

This inventor holds 1 USPTO granted patent. Top assignee: Roche Diagnostic Systems, Inc.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charles Minnan Cheng. Retrieved from https://idiyas.com/inventor/charles-minnan-cheng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Charles Minnan Cheng

Introduction

Charles Minnan Cheng is an accomplished inventor based in Bridgewater, NJ (US). He has made significant contributions to the field of immunochemical assays, particularly in the quantitation of aminoglycoside antibiotics. His work has implications for both medical diagnostics and pharmaceutical research.

Latest Patents

Cheng holds a patent for an invention titled "Assay for aminoglycoside antibiotics." This invention focuses on the use of polycarboxylic acid polymers to enhance the performance of immunochemical assays. The goal is to improve the quantitation of aminoglycoside antibiotics in biological samples. Additionally, this invention addresses the development of improved homogeneous immunochemical detection assays resulting from the incorporation of these polymers.

Career Highlights

Charles Minnan Cheng is associated with Roche Diagnostic Systems, Inc., where he applies his expertise in the development of diagnostic technologies. His work at Roche has allowed him to contribute to advancements in medical diagnostics, particularly in the detection of antibiotics.

Collaborations

(Section skipped due to space constraints.)

Conclusion

Charles Minnan Cheng's innovative work in the field of immunochemical assays demonstrates the importance of scientific advancements in medical diagnostics. His contributions continue to influence the way aminoglycoside antibiotics are quantified in biological samples.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…